SCHEMBL3165120

SCHEMBL3165120

CC(=O)NCCNc1cc(NC(=O)CN2CCC(O)(Cc3ccc(F)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ UTS2R Q9UKP6 5/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ TMEM97 Q5BJF2 1/20 0.39
▸ SIGMAR1 Q99720 1/20 0.39
▸ SSTR5 P35346 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ADORA3 P0DMS8 4/20 0.39
▸ ADORA2A P29274 4/20 0.39
▸ ADORA1 P30542 3/20 0.39
▸ ADORA2B P29275 3/20 0.39
▸ CFTR P13569 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162879 0.94 UTS2R (0.44) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL3165572 0.92 ALDH1A1 (0.42) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL3155741 0.91 ADORA3 (0.48) USP2ADORA3ADORA2BSMN1; SMN2
SCHEMBL3174273 0.86 TSHR (0.46) ALDH1A1USP2ADORA3ADORA2AADORA1
SCHEMBL3171582 0.85 MEN1 (0.47) ALDH1A1USP2ADORA3ADORA2AADORA1
SCHEMBL3162785 0.85 MEN1 (0.54) HTR2AALDH1A1SMN1; SMN2
SCHEMBL3161698 0.84 ALDH1A1 (0.54) ALDH1A1USP2SMN1; SMN2
SCHEMBL3165134 0.84 ALDH1A1 (0.48) ALDH1A1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL3164705 0.82 SMN1; SMN2 (0.57) HTR2AALDH1A1SMN1; SMN2
SCHEMBL3169342 0.82 CA1 (0.45) ALDH1A1USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback